Supply chain shortages have improved from their all-time high in Q1 2024. Yet, risks remain high, especially with the increased level of vulnerabilities.
Opportunities to increase market share will increase when companies are pre-positioned for growth in a resilient and scalable way.
Volatility, uncertainty, complexity, and ambiguity (VUCA) have plagued medtech’s supply chain since the pandemic. Drug shortages last year hit their highest levels in a decade, with 99% of hospital and health system pharmacists experiencing medicinal dearths, according to an American Society of Health System Pharmacists (ASHP) survey.
Escalating conflict in the Red Sea has exposed the vulnerability of global pharmaceutical supply chains and reinforced the importance of building more resilient sourcing and logistics strategies. In this interview, Lisa Anderson discusses how Houthi attacks on commercial shipping are increasing transportation costs, extending transit times, and prompting pharmaceutical [...]
The medical device market is expected to grow by almost $178 billion from 2023 to 2027 according to Technavio. Moreover, a Fortune Business Insights Analysis estimates the market to reach $799 billion by 2030. With such significant growth, manufacturing and supply chains must scale and mitigate risk to ensure supplies to customers and patients.
COVID-19 may no longer be a significant public health threat, but the global supply chain remains chock full of risk. The threats are seemingly everywhere these days: The Israel-Hamas war, which is sabotaging trade routes in the Red Sea; extreme drought, which is curtailing shipping in the Panama Canal, and China’s military aggression, which is threatening lawful commerce in the South China Sea.
Since packaging is typically 10-40% of the retail price of products, there is no doubt it adds up to a relevant factor in product cost and waste.
The supply chain has calmed down since the height of the pandemic; however, smart manufacturers are thinking ahead to changing conditions. Geopolitical risks are at an all-time high.
As companies are searching for ways to successfully navigate these turbulent times, the best ones are achieving a win-win focus on the customer and costs. Since the pandemic, there has been a heightened awareness of the customer experience as companies struggled with supply chain disruptions, delays, shortages, and the lack of resources.
Medtech companies’ focus on supply chain resiliency and mitigating supply chain risk has increased over the last few years as the pandemic triggered extended lead times, delays, and rising costs.
